Investigation Overview
An investigation on behalf of investors in shares of Vistagen Therapeutics Inc (NASDAQ:VTGN) was announced over potential breaches of fiduciary duties by certain officers and directors at Vistagen Therapeutics. The investigation by a law firm concerns whether certain Vistagen Therapeutics Inc (NASDAQ:VTGN officers and directors breached their fiduciary duties and caused damage to the...
You must register (for free) or login to view the entire investigation.